These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36596533)

  • 21. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple Adherence Tool Evaluation Study (MATES).
    Witry MJ; Doucette WR; Zhang Y; Farris KB
    J Manag Care Spec Pharm; 2014 Jul; 20(7):734-40. PubMed ID: 24967526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
    Sato N; Fujita K; Kushida K; Chen TF
    Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concordance-based adherence support service delivery: consumer perspectives.
    Du Pasquier S; Aslani P
    Pharm World Sci; 2008 Dec; 30(6):846-53. PubMed ID: 18592393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication adherence communications in community pharmacies: A naturalistic investigation.
    Rickles NM; Young GJ; Hall JA; Noland C; Kim A; Peterson C; Hong M; Hale J
    Patient Educ Couns; 2016 Mar; 99(3):386-392. PubMed ID: 26603505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structural and process aspects of pharmacy quality: older adults' perceptions.
    Shiyanbola OO; Mott DA; Croes KD
    Int J Clin Pharm; 2016 Feb; 38(1):96-106. PubMed ID: 26499502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Clinical Pharmacy in Switzerland: Involvement of Community Pharmacists in Care for Older Patients.
    Hersberger KE; Messerli M
    Drugs Aging; 2016 Mar; 33(3):205-11. PubMed ID: 26884391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancing the use of community pharmacy quality measures: a qualitative study.
    Shiyanbola OO; Mort JR; Lyons K
    J Am Pharm Assoc (2003); 2013; 53(4):400-7. PubMed ID: 23892813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives on an amended law addressing pharmacists' availability in community pharmacies.
    Qadeer G; Amin MEK
    J Eval Clin Pract; 2021 Feb; 27(1):151-157. PubMed ID: 32319720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptions of pharmacists and patients on information provision and their influence on patient satisfaction in Japanese community pharmacies.
    Takaki H; Abe T; Hagihara A
    J Eval Clin Pract; 2015 Dec; 21(6):1135-41. PubMed ID: 26268798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentially preventable medication-related hospitalizations: A clinical pharmacist approach to assessment, categorization, and quality improvement.
    Pellegrin KL; Lee E; Uyeno R; Ayson C; Goo R
    J Am Pharm Assoc (2003); 2017; 57(6):711-716. PubMed ID: 28823545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs.
    Pringle JL; Boyer A; Conklin MH; McCullough JW; Aldridge A
    Health Aff (Millwood); 2014 Aug; 33(8):1444-52. PubMed ID: 25092847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a pharmacist-led intervention to improve medication adherence in patients initiating dabigatran treatment: a comparison with standard pharmacy practice in Poland.
    Merks P; Cameron JD; Balcerzak M; Religioni U; Świeczkowski D; Konstanty M; Hering D; Szymański FM; Jaguszewski M; Vaillancourt R
    BMC Prim Care; 2022 Aug; 23(1):210. PubMed ID: 35986241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Theory of Planned Behavior informed factorial survey of New York community pharmacists to determine their intentions to monitor antihypertensive medication adherence among older adults.
    Unni E; Han J; Dillon P
    J Am Pharm Assoc (2003); 2022; 62(5):1572-1580. PubMed ID: 35469773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative.
    Krueger KP; Felkey BG; Berger BA
    J Am Pharm Assoc (2003); 2003; 43(6):668-78; quiz 678-9. PubMed ID: 14717263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial.
    Bertilsson E; Serhal S; Emmerton L; Bosnic-Anticevich S; Krass I; Bereznicki B; Bereznicki L; Armour C; Saini B
    Res Social Adm Pharm; 2021 Mar; 17(3):595-605. PubMed ID: 32448767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.